| Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy L Apetoh, F Ghiringhelli, A Tesniere, M Obeid, C Ortiz, A Criollo, G Mignot, ... Nature medicine 13 (9), 1050-1059, 2007 | 3337 | 2007 |
| Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors F Ghiringhelli, L Apetoh, A Tesniere, L Aymeric, Y Ma, C Ortiz, ... Nature medicine 15 (10), 1170-1178, 2009 | 2020 | 2009 |
| LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells A Brand, K Singer, GE Koehl, M Kolitzus, G Schoenhammer, A Thiel, ... Cell metabolism 24 (5), 657-671, 2016 | 1329 | 2016 |
| A novel dendritic cell subset involved in tumor immunosurveillance J Taieb, N Chaput, C Ménard, L Apetoh, E Ullrich, M Bonmort, ... Nature medicine 12 (2), 214-219, 2006 | 534 | 2006 |
| IL-18 induces PD-1–dependent immunosuppression in cancer M Terme, E Ullrich, L Aymeric, K Meinhardt, M Desbois, N Delahaye, ... Cancer research 71 (16), 5393-5399, 2011 | 400 | 2011 |
| Natural killer cell–directed therapies: moving from unexpected results to successful strategies M Terme, E Ullrich, NF Delahaye, N Chaput, L Zitvogel Nature immunology 9 (5), 486-494, 2008 | 391 | 2008 |
| Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ... Nature medicine 24 (3), 282-291, 2018 | 255 | 2018 |
| Ecto‐calreticulin in immunogenic chemotherapy M Obeid, A Tesniere, T Panaretakis, R Tufi, N Joza, P Van Endert, ... Immunological reviews 220 (1), 22-34, 2007 | 252 | 2007 |
| Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany N Albinger, J Hartmann, E Ullrich Gene therapy 28 (9), 513-527, 2021 | 212 | 2021 |
| Selection and expansion of natural killer cells for NK cell-based immunotherapy PSA Becker, G Suck, P Nowakowska, E Ullrich, E Seifried, P Bader, ... Cancer Immunology, Immunotherapy 65, 477-484, 2016 | 203 | 2016 |
| Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma S Oelsner, ME Friede, C Zhang, J Wagner, S Badura, P Bader, E Ullrich, ... Cytotherapy 19 (2), 235-249, 2017 | 174 | 2017 |
| Shaping of natural killer cell antitumor activity by ex vivo cultivation M Granzin, J Wagner, U Köhl, A Cerwenka, V Huppert, E Ullrich Frontiers in immunology 8, 257309, 2017 | 163 | 2017 |
| Molecular and functional characterization of the small Ca2+-regulated K+ channel (rSK4) of colonic crypts R Warth, K Hamm, M Bleich, K Kunzelmann, T von Hahn, R Schreiber, ... Pflügers Archiv 438, 437-444, 1999 | 157 | 1999 |
| Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma A Scholz, PN Harter, S Cremer, BH Yalcin, S Gurnik, M Yamaji, ... EMBO molecular medicine 8 (1), 39-57, 2016 | 156 | 2016 |
| Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol U Koehl, C Brehm, S Huenecke, SY Zimmermann, S Kloess, M Bremm, ... Frontiers in oncology 3, 118, 2013 | 144 | 2013 |
| New prospects on the NKG2D/NKG2DL system for oncology E Ullrich, J Koch, A Cerwenka, A Steinle Oncoimmunology 2 (10), e26097, 2013 | 142 | 2013 |
| Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment GF Heidkamp, J Sander, CHK Lehmann, L Heger, N Eissing, A Baranska, ... Science immunology 1 (6), eaai7677, 2016 | 139 | 2016 |
| IFN-α skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo C Papewalis, B Jacobs, M Wuttke, E Ullrich, T Baehring, R Fenk, ... The Journal of Immunology 180 (3), 1462-1470, 2008 | 139 | 2008 |
| Cancer-induced immunosuppression: IL-18–elicited immunoablative NK cells M Terme, E Ullrich, L Aymeric, K Meinhardt, JD Coudert, M Desbois, ... Cancer research 72 (11), 2757-2767, 2012 | 130 | 2012 |
| Tumor stress, cell death and the ensuing immune response E Ullrich, M Bonmort, G Mignot, G Kroemer, L Zitvogel Cell Death & Differentiation 15 (1), 21-28, 2008 | 122 | 2008 |
